🟢 HCW Biologics is trading 5.45% up in pre-market alongside a 2.08% biotech sector gain

HCW Biologics is trading at $1.16, up 5.45%, alongside a supplied pre-market biotech sector gain of 2.08%.

• No new company-specific announcement was identified; the latest company release listed is dated October 9.
• Recent reporting also described biotech gains alongside broader market strength.
• HCW Biologics is scheduled to announce quarterly earnings Thursday; results were not available in the sources reviewed.